Literature DB >> 8065461

Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.

P T Männistö1, A Lang, J Harro, E Peuranen, J Bradwejn, E Vasar.   

Abstract

We compared the influence of two cholecystokinin (CCK) antagonists, devazepide and L-365,260 [3R-(+)-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3y l)-N'-(3-methyl-phenyl)urea], upon two distinct phenomena, behavioural and hormonal effects of caerulein (5 micrograms/kg s.c.), and unselective CCK agonist, in rats. Behavioural effects were assessed in the elevated plus-maze and open field tests. In separate experiments, effects on thyrotropin (TSH), prolactin (PRL) and growth hormone (GH) levels in serum of male rats were studied. Caerulein inhibited the exploratory behaviour in the plus-maze. Time spent in the open part, the number of line crossings and closed arm entries were significantly decreased, whereas the ratio of failed attempts/closed arm entries was increased. The anti-exploratory effect of caerulein was antagonized by the pretreatment with L-365,260 (10 micrograms/kg), a preferential antagonist at CCKB receptors, but was increased by devazepide (1-100 micrograms/kg), a preferential CCKA antagonist. L-365,260 (1-100 micrograms/kg) and devazepide (1-100 micrograms/kg) given alone did not change the behaviour of rats in the plus-maze test. Caerulein (5 micrograms/kg) itself did not modify the locomotor activity of rats in open field. However, the concomitant administration of caerulein with devazepide (1-10 micrograms/kg) reduced the frequency of line crossings and rearings. In the hormonal studies caerulein significantly decreased the cold-induced increase of TSH levels in serum. GH and PRL levels were not markedly affected by caerulein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065461     DOI: 10.1007/bf00169136

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  45 in total

Review 1.  Neuropeptides in perspective: the last ten years.

Authors:  T Hökfelt
Journal:  Neuron       Date:  1991-12       Impact factor: 17.173

2.  Cholecystokinin-4 and panic.

Authors:  J L Abelson; R M Nesse
Journal:  Arch Gen Psychiatry       Date:  1990-04

3.  Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.

Authors:  M F O'Neill; C T Dourish; S D Iversen
Journal:  Eur J Pharmacol       Date:  1991-02-07       Impact factor: 4.432

4.  Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat.

Authors:  J Harro; E Vasar
Journal:  Eur J Pharmacol       Date:  1991-02-14       Impact factor: 4.432

Review 5.  CCK in animal and human research on anxiety.

Authors:  J Harro; E Vasar; J Bradwejn
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

6.  The effect of cholecystokinin octapeptide on pituitary-adrenal hormone secretion.

Authors:  J R Porter; L D Sander
Journal:  Regul Pept       Date:  1981-08

7.  Bio-assay of prolactin. Analysis of the pigeon crop-sac response to local prolactin injection by an objective and quantitative method.

Authors:  C S Nicoll
Journal:  Endocrinology       Date:  1967-04       Impact factor: 4.736

8.  Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones.

Authors:  J Bradwejn; C de Montigny
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

9.  Changes at cholecystokinin receptors induced by long-term treatment with diazepam and haloperidol.

Authors:  E Vasar; A Soosaar; J Harro; A Lang
Journal:  Eur Neuropsychopharmacol       Date:  1992-12       Impact factor: 4.600

10.  Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.

Authors:  F H Marshall; S Barnes; J Hughes; G N Woodruff; J C Hunter
Journal:  J Neurochem       Date:  1991-03       Impact factor: 5.372

View more
  5 in total

1.  Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.

Authors:  P W Frankland; S A Josselyn; J Bradwejn; F J Vaccarino; J S Yeomans
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

2.  Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.

Authors:  S Kõks; P T Männistö; M Bourin; J Shlik; V Vasar; E Vasar
Journal:  J Psychiatry Neurosci       Date:  2000-01       Impact factor: 6.186

3.  Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

Authors:  N J Johnson; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

4.  Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.

Authors:  Di Wen; Chun-Ling Ma; Ya-Jing Zhang; Yan-Xin Meng; Zhi-Yu Ni; Shu-Jin Li; Bin Cong
Journal:  BMC Neurosci       Date:  2012-06-08       Impact factor: 3.288

5.  Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.

Authors:  Hailei Yu; Di Wen; Chunling Ma; Yanxin Meng; Shujin Li; Zhiyu Ni; Bin Cong
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.